Faes Farma, S.A. (FAE.MC)
EUR 3.33
(-2.49%)
EUR 3.33
(-2.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 297.11 Million EUR | 5.36% |
| 2022 | 282.01 Million EUR | 11.73% |
| 2021 | 252.39 Million EUR | 5.24% |
| 2020 | 239.83 Million EUR | 5.46% |
| 2019 | 227.41 Million EUR | 11.4% |
| 2018 | 204.13 Million EUR | 14.59% |
| 2017 | 178.14 Million EUR | 17.82% |
| 2016 | 151.19 Million EUR | 13.03% |
| 2015 | 133.76 Million EUR | 6.13% |
| 2014 | 126.03 Million EUR | 9.93% |
| 2013 | 114.64 Million EUR | 1.4% |
| 2012 | 113.06 Million EUR | -2.45% |
| 2011 | 115.89 Million EUR | -2.25% |
| 2010 | 118.56 Million EUR | -9.19% |
| 2009 | 130.56 Million EUR | 13.64% |
| 2008 | 114.89 Million EUR | -0.41% |
| 2007 | 115.36 Million EUR | -37.7% |
| 2006 | 185.18 Million EUR | 11.26% |
| 2005 | 166.44 Million EUR | 59.42% |
| 2004 | 104.4 Million EUR | -6.81% |
| 2003 | 112.03 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 93.25 Million EUR | -3.96% |
| 2024 Q1 | 97.1 Million EUR | 15.77% |
| 2023 FY | 297.11 Million EUR | 5.36% |
| 2023 Q3 | 73.46 Million EUR | 9.31% |
| 2023 Q4 | 83.87 Million EUR | 14.17% |
| 2023 Q1 | 90.91 Million EUR | 84.19% |
| 2023 Q2 | 67.2 Million EUR | -26.07% |
| 2022 Q2 | 66.98 Million EUR | -19.71% |
| 2022 Q3 | 82.24 Million EUR | 22.78% |
| 2022 Q4 | 49.35 Million EUR | -39.99% |
| 2022 Q1 | 83.42 Million EUR | 125.37% |
| 2022 FY | 282.01 Million EUR | 11.73% |
| 2021 Q2 | 53.84 Million EUR | -24.74% |
| 2021 FY | 252.39 Million EUR | 5.24% |
| 2021 Q4 | 37.01 Million EUR | -58.86% |
| 2021 Q3 | 89.98 Million EUR | 67.1% |
| 2021 Q1 | 71.55 Million EUR | 150.91% |
| 2020 FY | 239.83 Million EUR | 5.46% |
| 2020 Q1 | -33 Million EUR | -110.88% |
| 2020 Q2 | 163.07 Million EUR | 594.1% |
| 2020 Q3 | 81.24 Million EUR | -50.18% |
| 2020 Q4 | 28.51 Million EUR | -64.9% |
| 2019 Q3 | -193.04 Million EUR | -233.12% |
| 2019 Q2 | 145.02 Million EUR | 617.16% |
| 2019 FY | 227.41 Million EUR | 11.4% |
| 2019 Q1 | -28.04 Million EUR | -151.23% |
| 2019 Q4 | 303.47 Million EUR | 257.2% |
| 2018 Q2 | 52.82 Million EUR | 1.19% |
| 2018 Q4 | 54.73 Million EUR | 23.33% |
| 2018 FY | 204.13 Million EUR | 14.59% |
| 2018 Q1 | 52.2 Million EUR | 10.97% |
| 2018 Q3 | 44.38 Million EUR | -15.98% |
| 2017 Q3 | 170.2 Million EUR | 310.64% |
| 2017 FY | 178.14 Million EUR | 17.82% |
| 2017 Q1 | 41.7 Million EUR | -79.63% |
| 2017 Q4 | 47.04 Million EUR | -72.36% |
| 2017 Q2 | -80.8 Million EUR | -293.77% |
| 2016 FY | 151.19 Million EUR | 13.03% |
| 2016 Q4 | 204.69 Million EUR | 1254.76% |
| 2016 Q3 | -17.72 Million EUR | -6.31% |
| 2016 Q2 | -16.67 Million EUR | 12.7% |
| 2016 Q1 | -19.1 Million EUR | -110.59% |
| 2015 Q2 | -16.77 Million EUR | -2.29% |
| 2015 Q3 | -13.38 Million EUR | 20.2% |
| 2015 Q4 | 180.33 Million EUR | 1447.06% |
| 2015 FY | 133.76 Million EUR | 6.13% |
| 2015 Q1 | -16.4 Million EUR | -109.79% |
| 2014 Q3 | -13.5 Million EUR | -2.57% |
| 2014 Q4 | 167.59 Million EUR | 1341.1% |
| 2014 Q2 | -13.16 Million EUR | 11.58% |
| 2014 FY | 126.03 Million EUR | 9.93% |
| 2014 Q1 | -14.89 Million EUR | -291.67% |
| 2013 Q2 | -61.82 Million EUR | -277.29% |
| 2013 Q3 | 133.83 Million EUR | 316.46% |
| 2013 Q4 | 7.76 Million EUR | -94.2% |
| 2013 FY | 114.64 Million EUR | 1.4% |
| 2013 Q1 | 34.87 Million EUR | 200.27% |
| 2012 Q1 | 32.53 Million EUR | 174.68% |
| 2012 Q3 | 87.21 Million EUR | 665.81% |
| 2012 FY | 113.06 Million EUR | -2.45% |
| 2012 Q4 | -34.78 Million EUR | -139.88% |
| 2012 Q2 | 11.38 Million EUR | -65.0% |
| 2011 Q1 | 56.47 Million EUR | 0.0% |
| 2011 Q4 | -43.57 Million EUR | -144.64% |
| 2011 Q3 | 97.61 Million EUR | 1715.76% |
| 2011 FY | 115.89 Million EUR | -2.25% |
| 2011 Q2 | 5.37 Million EUR | -90.48% |
| 2010 Q1 | 52.7 Million EUR | 0.0% |
| 2010 FY | 118.56 Million EUR | -9.19% |
| 2010 Q2 | 12.09 Million EUR | -77.05% |
| 2009 FY | 130.56 Million EUR | 13.64% |
| 2008 FY | 114.89 Million EUR | -0.41% |
| 2007 FY | 115.36 Million EUR | -37.7% |
| 2006 FY | 185.18 Million EUR | 11.26% |
| 2005 FY | 166.44 Million EUR | 59.42% |
| 2004 FY | 104.4 Million EUR | -6.81% |
| 2003 FY | 112.03 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Almirall, S.A. | 577.11 Million EUR | 48.517% |
| Laboratorio Reig Jofre, S.A. | 85.17 Million EUR | -248.836% |